Literature DB >> 11798146

Role of mesangial expansion in the pathogenesis of diabetic nephropathy.

M Dalla Vestra1, A Saller, M Mauer, P Fioretto.   

Abstract

Glomerulopathy, characterized by thickening of the glomerular basement membrane (GBM) and mesangial expansion, is the most important renal structural change in type 1 diabetic patients with diabetic nephropathy. Morphological lesions develop concomitantly in the arterioles, tubules and interstitium. Mesangial fractional volume [Vv(mes/glom)], an estimate of mesangial expansion, is the structural parameter that best correlates with glomerular filtration rate (GFR) and it is also closely related to the presence of proteinuria and hypertension. Diabetic glomerulopathy has also been described in type 2 diabetic patients, but glomerular lesions are milder than in type 1 diabetic patients. In type 2 diabetes glomerular structural parameters are, on average, altered. However, despite persistent microalbuminuria or proteinuria, several patients have normal glomerular structure. Renal structure is, in fact, heterogeneous in type 2 diabetic patients: only a subset has typical diabetic glomerulopathy, while a substantial proportion has more advanced tubulo-interstitial and vascular rather than glomerular lesions, or has normal or near normal renal structure. Also in type 2 diabetes mesangial expansion is related to renal functional parameters, but although significant, these structural-functional relationships are less precise than in type 1 diabetes. Thus, both in type 1 and in type 2 diabetes, mesangial expansion is the most important structural change. Finally, we have recently demonstrated that, the lesions of diabetic glomerulopathy can be reversed in humans. This amelioration in glomerular structure was observed after long-term normoglycemia obtained by pancreas transplantation. This is a new concept in nephrology, and the understanding of the mechanisms involved in the glomerular architectural remodelling might have important clinical and therapeutic implications.

Entities:  

Mesh:

Year:  2001        PMID: 11798146

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  26 in total

1.  Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy.

Authors:  Ze-Bo Hu; Kun-Ling Ma; Yang Zhang; Gui-Hua Wang; Liang Liu; Jian Lu; Pei-Pei Chen; Chen-Chen Lu; Bi-Cheng Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

Review 2.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 3.  Calcium-permeable ion channels in the kidney.

Authors:  Yiming Zhou; Anna Greka
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-30

Review 4.  Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism.

Authors:  Weier Qi; Qian Li; Daniel Gordin; George L King
Journal:  J Mol Med (Berl)       Date:  2018-03-24       Impact factor: 4.599

5.  Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway.

Authors:  Dan Zhu; Hongwei Yu; Hongjiang He; Jiuli Ding; Jie Tang; Dan Cao; Lirong Hao
Journal:  Mol Cell Biochem       Date:  2013-04-29       Impact factor: 3.396

6.  SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway.

Authors:  Jin-Lan Xu; Xin-Xin Gan; Jun Ni; De-Cui Shao; Yang Shen; Nai-Jun Miao; Dan Xu; Li Zhou; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2018-05-10       Impact factor: 6.150

7.  Mycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro.

Authors:  Wei Lv; Jingqiu Lou; Yan Zhang; Peiwen Lian; Dong Qi; Jianping Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  The use of lysosomal enzymuria in the early detection and monitoring of the progression of diabetic nephropathy.

Authors:  Donatien Gatsing; Ibrahim Hassan Garba; Godwin I Adoga
Journal:  Indian J Clin Biochem       Date:  2006-09

Review 9.  Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

Authors:  Prasad Bichu; Ravi Nistala; Asma Khan; James R Sowers; Adam Whaley-Connell
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  The role of reactive oxygen species in apoptosis of the diabetic kidney.

Authors:  F A D T G Wagener; D Dekker; J H Berden; A Scharstuhl; J van der Vlag
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.